About The Medical Condition Drug Evaluation, FDA Phase 2
Find the definition of the medical term Drug Evaluation, FDA Phase 2. Drug Evaluation, FDA Phase 2 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase 2
| Drug Evaluation, FDA Phase 2 Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase 2?
Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Hospitals, Proprietary ‐ Hospitals owned and operated by a corporation or an individual…
- Myxedemas, Congenital ‐ A condition due to congenital lack of thyroid hormone, marked…
- Ketosuccinates ‐ Salts and esters of…
- Cross Reaction ‐ Serological reactions in which an antiserum against one antigen…
- Venoms, Scorpion ‐ Venoms from animals of the order Scorpionida of the class Arachnida.…
- Neoplasms, Ureter ‐ Cancer or tumors of the URETER. Hematuria, which occurs in 75%…
- Antagonists, Blood Platelet ‐ Drugs or agents which antagonize or impair any mechanism leading…
- Carminomicin ‐ A very toxic anthracycline-type antibiotic related to DAUNORUBICIN,…
- Elbow, Tennis ‐ A condition characterized by pain in or near the lateral humeral…
- Tryptan ‐ An essential amino acid that is necessary for normal growth in…